Modulators of oral health-related quality of life of maxillary implant overdenture users, analysed with the QoLIP-10, QoLDAS-9, and QoLFAST-10 specific questionnaires.

Objectives: To identify potential modulators of OHRQoL in patients with maxillary implant-retained overdentures using specific implant-prosthesis questionnaires.

Methods: In this cross-sectional observational study, 70 volunteers with maxillary implant overdentures were divided into two balanced groups (n=35 each) concerning gender and partnership status. The participants completed the QoLIP-10, QoLDAS-9, and QoLFAST-10 scales.

Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients.

One of the most urgent needs worldwide is to vaccinate against SARS-CoV-2 as many people as possible. We evaluated humoral response to Comirnaty vaccine in Thalassemia Major patients (TM). We measured SARS-CoV-2-specific antibodies against Spike protein in 57 TM patients and 58 healthy blood donors (HBD).

COVID-19 pneumonia and pulmonary microembolism in a patient with B-thalassemia major.

We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID-19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.

Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years.

In this study, we compared the long-term effects of different iron chelation regimens (deferoxamine, deferiprone, deferoxamine + deferiprone, and deferasirox) in preventing or reversing endocrinopathy (diabetes mellitus, hypothyroidism, or hypogonadism) and bone disease (measured through DEXA) in 165 adults with β-thalassemia major (TM) (mean age 39.9 ± 8.3 years, 43 % males).